CB Rank (Person) 812,316

Dr. Swiger is a successful researcher and developer in clinical Dx, forensics, and environmental testing. His 28-year career has spanned applications and devices widely utilized in government, commercial Dx, and testing-services markets. Notably, Roy was the Point of Contact (POC) for tech transfer of whole mouse chromosome paints for use in

fluorescence in situ hybridization (FISH) while at Lawrence Livermore National Laboratory (LLNL). While at MRIGlobal, he developed the PathAlertâ„¢ multiplex pathogen detection product-line licensed to Invitrogen/Thermo- Fisher and co-marketed with Agilent. He served as CSO for Escent Technologies where he led a team developing a handheld NIR-instrument used for particulate and powder analysis to identify illegal drugs, pharmaceuticals, and pathogens. More recently, as the Director of Advanced Technology Programs at IntegenX Inc., Dr. Swiger contributed to the development and commercialization of a portable, autonomous sample-in/answer-out forensic DNA-lab-in-a-box, acquired by Thermo-Fisher Life Technologies. Dr. Swiger has the hard-to-find balance of technical and business skills needed to lead Acenxion Biosystems.

Number of Current Jobs 1
Roy Swiger is the CEO at Acenxion Biosystems.
Roy Swiger studied at York University.
There is no recent news or activity for this profile.